Related Experiment Videos
Effect of reserpine treatment on enkephalin mRNA level in the rat striatum: an in situ hybridization study
1E.P. 74 CNRS, Laboratoire d'Histologie-Embryologie (U.F.R. II), Université de Bordeaux II, France.
Abstract:
We investigated the molecular mechanisms responsible for the preproenkephalin A mRNA increase following catecholamine depletion by reserpine using quantitative in situ hybridization at the cellular level. Macroscopic analysis showed that short term reserpine treatment increases the preproenkephalin A mRNA level in the rat striatum to +40.2 +/- 9%. Microautoradiography analysis demonstrated different increases in the preproenkephalin A mRNA level in different parts of the striatum: +124 +/- 22% in the dorso-median striatum, +131 +/- 19% in the dorso-lateral striatum, +119 +/- 8% in the ventro-lateral striatum and +75 +/- 6% in the ventro-median striatum. We found no difference in the number of cells expressing PPA mRNA in reserpine treated rats suggesting that these increases are only due to an increase in the number of mRNA expressed by cell.
Insights
Reserpine treatment increases preproenkephalin A mRNA in rat striatum. This rise in peptide expression is due to increased mRNA per cell, not more cells expressing it.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Catecholamine depletion is known to affect gene expression in the brain.
- Preproenkephalin A (PPA) is a key peptide involved in pain and reward pathways.
- Understanding PPA regulation is crucial for neurological research.
Purpose of the Study:
- To investigate the cellular mechanisms behind the increase in preproenkephalin A mRNA after catecholamine depletion.
- To quantify the changes in PPA mRNA levels in different regions of the rat striatum.
Main Methods:
- Quantitative in situ hybridization was used for cellular-level analysis.
- Microautoradiography was employed to measure PPA mRNA levels.
- Reserpine was administered to deplete catecholamines in rats.
Main Results:
- Reserpine treatment increased overall striatal PPA mRNA by 40.2%.
- Significant regional variations in PPA mRNA increase were observed, ranging from +75% to +131%.
- The number of cells expressing PPA mRNA remained unchanged, indicating increased expression per cell.
Conclusions:
- Catecholamine depletion via reserpine upregulates PPA mRNA expression in the rat striatum.
- The observed increase in PPA mRNA is attributed to enhanced expression within existing cells, not an increase in cell numbers.
- These findings shed light on the molecular regulation of opioid peptide synthesis in response to neurochemical changes.